应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01302 先健科技
已收盘 08-03 16:08:12
1.375
-0.095
-6.46%
最高
1.500
最低
1.370
成交量
3,097万
今开
1.500
昨收
1.470
日振幅
8.84%
总市值
63.69亿
流通市值
63.69亿
总股本
46.32亿
成交额
4,325万
换手率
0.67%
流通股本
46.32亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
先健科技(01302)宣布终止收购华医股权及发行可换股债券计划
公告速递 · 07-20
先健科技(01302)宣布终止收购华医股权及发行可换股债券计划
先健科技公告重大交易:拟收购星途股权并发行可转换债券
美股速递 · 07-20
先健科技公告重大交易:拟收购星途股权并发行可转换债券
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
金吾财讯 · 07-17
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
先健科技6月股份变动月报表披露,股本维持稳定
公告速递 · 07-03
先健科技6月股份变动月报表披露,股本维持稳定
先健科技(01302):姜峰调任为独立非执行董事
智通财经 · 06-18
先健科技(01302):姜峰调任为独立非执行董事
【券商聚焦】中信建投:建议2026年加配医疗器械板块
金吾财讯 · 06-18
【券商聚焦】中信建投:建议2026年加配医疗器械板块
先健科技2026年5月股份变动月报表:股本维持稳定
公告速递 · 06-02
先健科技2026年5月股份变动月报表:股本维持稳定
新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问
经济参考网 · 05-28
新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问
港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价
智通财经 · 05-26
港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
新浪港股 · 05-26
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
新浪港股 · 05-24
先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权
先健科技拟通过可转债收购思达医疗科技96.46%股权
投资观察 · 05-22
先健科技拟通过可转债收购思达医疗科技96.46%股权
先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权
智通财经 · 05-22
先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权
先健科技(01302):刘剑雄辞任执行董事及公司授权代表
智通财经 · 05-22
先健科技(01302):刘剑雄辞任执行董事及公司授权代表
先健科技4月股份变动月报:股本维持稳定
公告速递 · 05-07
先健科技4月股份变动月报:股本维持稳定
先健科技拟回购最多一成股份
公告速递 · 05-06
先健科技拟回购最多一成股份
【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会
金吾财讯 · 04-21
【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会
【券商聚焦】华安证券维持先健科技(01302)“买入”评级 指其外周业务驱动增长并切入电生理新赛道
金吾财讯 · 04-14
【券商聚焦】华安证券维持先健科技(01302)“买入”评级 指其外周业务驱动增长并切入电生理新赛道
先健科技3月未有新增股份发行 股本维持不变
公告速递 · 04-08
先健科技3月未有新增股份发行 股本维持不变
异动解读 | 先健科技盘中大涨5.49%,因出现大手买入
异动解读 · 04-08
异动解读 | 先健科技盘中大涨5.49%,因出现大手买入
加载更多
公司概况
公司名称:
先健科技
所属市场:
SEHK
上市日期:
--
主营业务:
先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01302","market":"HK","secType":"STK","nameCN":"先健科技","latestPrice":1.375,"timestamp":1785744492003,"preClose":1.47,"halted":0,"volume":30965275,"delay":0,"changeRate":-0.06462585034013604,"floatShares":4632000000,"shares":4632000000,"eps":0.03829267011190489,"marketStatus":"已收盘","change":-0.095,"latestTime":"08-03 16:08:12","open":1.5,"high":1.5,"low":1.37,"amount":43246311,"amplitude":0.088435,"askPrice":1.375,"askSize":906000,"bidPrice":1.37,"bidSize":866000,"shortable":3,"etf":0,"ttmEps":0.03829267011190489,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785807000000},"marketStatusCode":5,"adr":0,"listingDate":1320854400000,"exchange":"SEHK","adjPreClose":1.47,"openAndCloseTimeList":[[1785720600000,1785729600000],[1785733200000,1785744000000]],"volumeRatio":2.410349,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01302","defaultTab":"news","newsList":[{"id":"1176798974","title":"先健科技(01302)宣布终止收购华医股权及发行可换股债券计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1176798974","media":"公告速递","labels":["executive","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176798974?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:13","pubTimestamp":1784545981,"startTime":"0","endTime":"0","summary":"香港,2026年7月20日,先健科技有限公司发布公告称,公司董事会已决定不再推进此前拟议的收购华医股权及根据特别授权发行可换股债券的主要交易。公告显示,先健科技与卖方就股权购买协议及可换股债券票据等最终交易文件已进行谈判,但双方迄今未能达成一致。基于审慎考虑并为消除潜在不确定因素,董事会决定终止交易;相关的可换股债券发行及特别授权事项亦将不再进行,公司亦不会就此向股东寄发通函或召开股东特别大会。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100235998","title":"先健科技公告重大交易:拟收购星途股权并发行可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=1100235998","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100235998?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:52","pubTimestamp":1784544763,"startTime":"0","endTime":"0","summary":"先健科技宣布一项重大交易,涉及拟收购星途股权以及计划发行可转换债券。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1100","01302","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱,部分企业新品及海外驱动增长;医疗器械上游部分公司收入有望高增长;高值耗材受医疗合规要求提升影响,部分企业预计增长良好;IVD低基数下增速有望改善;家用器械部分企业有望延续高增长;医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会,建议关注国产替代向中高端延伸,看好出海、新科技(AI、脑机接口)及并购整合等新技术落地。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1615","09996","BK1247","00853","BK1584","06826","BK1100","BK1515","KCE","159873","LU0287142896.SGD","BK1189","BK1587","LU0173614495.USD","BK1617","01066","BK0276","BK1574","BK1593","BK1571","HK0000165453.HKD","02190","BK1589","BK1502","BK1591","BK1583","601066","BK1161","BK1142","BK1585","BK1610","02252","BK1501","BK1222","00241","BK1600","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103534765","title":"先健科技6月股份变动月报表披露,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103534765","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103534765?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:56","pubTimestamp":1783068990,"startTime":"0","endTime":"0","summary":"2026年7月3日,先健科技披露了公司截至2026年6月30日的股份变动月报表。公告显示,公司本月底法定/注册股本总额为USD 50,000,与上月保持一致。法定/注册股份数目仍为40,000,000,000股,面值USD 0.00000125。截至报告期末,已发行股份总数为4,631,712,400股,与上月底相比无增减变动。公告指出,当月无新增发行股份或回购、注销及库藏股变动,整体股本保持稳定。本月内未通过期权行使产生新增发行股份或库藏股转让。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644401085","title":"先健科技(01302):姜峰调任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2644401085","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644401085?lang=zh_cn&edition=full","pubTime":"2026-06-18 20:48","pubTimestamp":1781786933,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先健科技(01302)发布公告,姜峰先生已由非执行董事调任为独立非执行董事,并已获委任为审核委员会及薪酬委员会各自的成员,自2026年6月18日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644732297","title":"【券商聚焦】中信建投:建议2026年加配医疗器械板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2644732297","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644732297?lang=zh_cn&edition=full","pubTime":"2026-06-18 09:24","pubTimestamp":1781745845,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券建议,2026年加配医疗器械板块,短期来看,建议把握2026年业绩改善个股的业绩和估值修复机会,多家医疗器械行业细分赛道龙头公司将于2026年迎来加速增长,同时建议关注手术机器人、脑机接口等新科技方向,相关技术突破和商业化落地有望持续催化板块热度。长期来看,医疗器械板块投资机会来自创新、出海和并购整合,板块的创新和国际化能力得到认可,估值正在重构。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984058","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","601066","09996","01066","LU0287142896.SGD","06826","BK1617","BK1222","BK1501","BK1589","LU0173614495.USD","BK1600","BK1574","BK1571","BK1593","BK1583","02190","BK1247","159883","BK1615","BK1100","02252","BK1142","BK1161","BK1587","BK1502","00853","BK1610","02235","01302","00241","BK1515","BK1585","BK0276","BK1584","BK1591","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106837755","title":"先健科技2026年5月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1106837755","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106837755?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:16","pubTimestamp":1780391797,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年6月2日发布2026年5月的证券变动月报表。报告显示,公司本月股本结构维持稳定,已发行股份数量及注册股本未发生变化。根据公告,截至2026年5月31日,先健科技的法定/注册股本仍为40,000,000,000股,每股面值为0.00000125美元,总计50,000美元,与上月保持一致。截至2026年5月末,先健科技股本总数依然维持在4,631,712,400股,同时符合香港联合交易所有限公司规定的最低公众持股量要求。本次公告由公司秘书刘剑雄签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638365694","title":"新华健康 | 高瓴资本意欲何为? 三度交易华医圣杰股权引追问","url":"https://stock-news.laohu8.com/highlight/detail?id=2638365694","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638365694?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:30","pubTimestamp":1779978629,"startTime":"0","endTime":"0","summary":"同一公司,高瓴资本先将其卖给健世科技(09877.HK),两年后又从健世科技手中买回来。如今,高瓴资本又将其卖给先健科技(01302.HK)。这笔交易一经披露,随即引起业界关注:高瓴资本如此腾挪意欲何为?先健科技近日披露了最新的交易方案。按照协议,公司拟作价18.73亿元收购北京华医圣杰科技有限公司(简称“华医圣杰”)96.46%股权,交易对手穿透后由高瓴资本控制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605283753111580.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283753111580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01302","BK1100","BK1583","BK1600","09877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638562912","title":"港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价","url":"https://stock-news.laohu8.com/highlight/detail?id=2638562912","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638562912?lang=zh_cn&edition=full","pubTime":"2026-05-26 11:00","pubTimestamp":1779764421,"startTime":"0","endTime":"0","summary":"消息面上,5月22日晚,先健科技发布公告称,拟以代价约18.733亿元向高瓴资本全资持有之AUT-VII收购国内先心封堵器厂商华医圣杰约96.46%股权,代价全部以发行可换股债券支付,双方并订立具法律约束力的框架协议。公告指出,可换股债券按年利率3.5%计息,每季以现金支付,为期3年,初始转换价为每股2.5港元,比5月22日收报2.31港元溢价约8.2%,悉数行使涉发行约8.6亿股新股,占扩大后股本约15.66%,将令高瓴成为先健科技的单一最大股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK4588","VXUS","BNDW","BK4585","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2638660845","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660845","media":"新浪港股","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638660845?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:52","pubTimestamp":1779756720,"startTime":"0","endTime":"0","summary":" 先健科技发布公告,于2026年5月22日,公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后,华医将成为公司的非全资附属公司,其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为,收购华医符合集团的整体发展策略,并将为公司带来长远的裨益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-26/doc-inhzequs2977158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1600","01302","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637308535","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637308535","media":"新浪港股","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637308535?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:27","pubTimestamp":1779611220,"startTime":"0","endTime":"0","summary":" 先健科技发布公告,于2026年5月22日,公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后,华医将成为公司的非全资附属公司,其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为,收购华医符合集团的整体发展策略,并将为公司带来长远的裨益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-24/doc-inhyytnk3397355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1583","01302","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193455178","title":"先健科技拟通过可转债收购思达医疗科技96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1193455178","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193455178?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:27","pubTimestamp":1779463664,"startTime":"0","endTime":"0","summary":"先健科技公司(股票代码:1302.HK)宣布,计划通过发行可转换债券的方式,收购思达医疗科技公司96.46%的股权。此项交易旨在进一步整合医疗技术资源,拓展公司在相关领域的业务布局。市场分析人士指出,此次收购若顺利完成,或将增强先健科技在医疗器械细分市场的竞争力,并为其带来新的增长动力。具体交易条款及后续进展有待公司进一步披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637034335","title":"先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637034335","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637034335?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:11","pubTimestamp":1779462692,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先健科技 发布公告,于2026年5月22日,公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后,华医将成为公司的非全资附属公司,其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为,收购华医符合集团的整体发展策略,并将为公司带来长远的裨益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权","news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01302","BK1600","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637214348","title":"先健科技(01302):刘剑雄辞任执行董事及公司授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2637214348","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637214348?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:57","pubTimestamp":1779461866,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先健科技(01302)发布公告,刘剑雄先生提呈辞任执行董事及公司授权代表的职务。冯小玲女士提呈辞任执行董事及董事会提名委员会成员的职务,以便彼等各自可将更多时间投入其他事务。经董事会批准,上述辞任将在于2026年5月22日召开的董事会会议上审议后立即生效。于上述辞任后,刘剑雄先生及冯小玲女士各自将继续以彼之其他现有角色及职责服务公司,即:刘剑雄先生将继续担任公司常务副总裁、首席财务官兼公司秘书;冯小玲女士将继续担任公司国际事业部副总裁。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01302","BK1600","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175970997","title":"先健科技4月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175970997","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175970997?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:41","pubTimestamp":1778143307,"startTime":"0","endTime":"0","summary":"先健科技于2026年5月7日披露截至2026年4月30日的股份变动月报表。报告显示,公司注册股本数量依旧为40,000,000,000股,每股面值USD 0.00000125,注册股本总额USD 50,000;已发行股本方面,截至2026年4月30日,公司普通股数量为4,631,712,400股,与上月底保持一致。月报显示,当月公司并未新增发行股份、购回股份或注销股份,亦没有产生任何库存股份变动。本次公告经公司秘书刘剑雄签署。根据本次月报披露信息,截至2026年4月30日,先健科技整体股本保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1144915415","title":"先健科技拟回购最多一成股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1144915415","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144915415?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:39","pubTimestamp":1778056752,"startTime":"0","endTime":"0","summary":"先健科技公司,于香港联合交易所有限公司主板上市,近日在董事会报告中公布了一项股份购回计划。该公司拟于股东周年大会上授予董事一般及无条件授权,可自决议通过之日起至下届股东周年大会结束、或公司章程规定的最后期限届满、或股东在股东大会上通过撤销或修订授权的普通决议日期孰先为止,回购不超过当日公司已发行股本10%的股份或可转换为股份的证券。根据公告,先健科技目前发行股本合计4,631,712,400股,意味最多可购回4.63亿股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先健科技拟回购最多一成股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629087757","title":"【券商聚焦】中信建投:医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为,医疗器械板块拐点已经来临,26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道,以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股,未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1161","BK1583","02190","BK1587","BK1589","02252","01066","BK1501","BK1571","02235","BK1600","BK1502","BK1142","601066","BK1574","BK1585","09996","01302","BK1247","00241","BK1189","00853","BK1515","BK1615","159883","BK0276","BK1100","LU0287142896.SGD","BK1593","BK1617","BK1584","BK1591","BK1610","BK1222","09997","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627541123","title":"【券商聚焦】华安证券维持先健科技(01302)“买入”评级 指其外周业务驱动增长并切入电生理新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2627541123","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627541123?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:19","pubTimestamp":1776158371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华安证券发布研报指,先健科技 2025年经调整后利润表现强劲,核心外周业务驱动增长,并通过战略投资切入电生理新赛道。报告维持对公司的“买入”评级。结构性心脏病业务收入为5.12亿元,同比微降3.0%。此外,公司完成对剑虎医疗第一阶段1亿元投资,获得其22.22%股权及电生理相关产品的独家优先合作权与海外独家经销权,正式战略切入电生理赛道,有望构筑新的长期增长点。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978933","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","600909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116016146","title":"先健科技3月未有新增股份发行 股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1116016146","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116016146?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:31","pubTimestamp":1775637072,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年4月8日发布截至2026年3月31日的股份变动月报表。报告显示,公司注册股本维持在40,000,000,000股,总额50,000美元,且已发行股份数量连续两个月保持在4,631,712,400股。报告期内,先健科技无新增股份发行、购回或注销,也无库存股变动。公司当月股份期权方面,共有350,000份期权失效,未有因行使期权而增发股份,至月末两项购股权计划下的剩余期权合计约308,818,750份,可行使数量保持稳定。该公告由公司秘书刘剑雄签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103414290","title":"异动解读 | 先健科技盘中大涨5.49%,因出现大手买入","url":"https://stock-news.laohu8.com/highlight/detail?id=1103414290","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103414290?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:03","pubTimestamp":1775635437,"startTime":"0","endTime":"0","summary":"先健科技(01302)今日盘中大涨5.49%,引起了市场的关注。消息面上,该股在下午交易时段出现大手买入,成交量为140万股,成交价为1.87港元,涉及资金261.8万港元。这种大额买入通常表明有机构投资者或大资金对该公司感兴趣,可能会推动股价上涨。在今日交易中,该股最高价为1.88港元,最低价为1.81港元,总成交量为2503万股,总成交金额为4629万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifetechmed.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0652},{"period":"3month","weight":-0.3194},{"period":"6month","weight":-0.1967},{"period":"1year","weight":-0.2794},{"period":"ytd","weight":-0.0577}],"compareEarnings":[{"period":"1week","weight":0.0369},{"period":"1month","weight":0.1313},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.0549},{"period":"1year","weight":0.0449},{"period":"ytd","weight":0.0099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.025079},{"month":2,"riseRate":0.384615,"avgChangeRate":0.028221},{"month":3,"riseRate":0.615385,"avgChangeRate":0.017514},{"month":4,"riseRate":0.538462,"avgChangeRate":0.025302},{"month":5,"riseRate":0.538462,"avgChangeRate":0.072446},{"month":6,"riseRate":0.538462,"avgChangeRate":0.041537},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.056658},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049509},{"month":9,"riseRate":0.583333,"avgChangeRate":0.031147},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004062},{"month":11,"riseRate":0.416667,"avgChangeRate":0.043537},{"month":12,"riseRate":0.384615,"avgChangeRate":0.000564}],"exchange":"SEHK","name":"先健科技","nameEN":"LIFETECH SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先健科技,01302,先健科技股票,先健科技股票老虎,先健科技股票老虎国际,先健科技行情,先健科技股票行情,先健科技股价,先健科技股市,先健科技股票价格,先健科技股票交易,先健科技股票购买,先健科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}